Source: Annual Congress 2008 - Novel experimental approaches to understanding asthma and COPD II
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
B. Burian, B. Marzluf, A. Storka, V. Petkov (Vienna, Austria). Antiinflammatory effects of formoterol in macrophages as a model for alveolar macrophages in COPD. Eur Respir J 2008; 32: Suppl. 52, 3667

Member's Comments

No comment yet.

Related content which might interest you: No evidence of corticosteroid resistance in COPD alveolar macrophages Source: Annual Congress 2009 - Translational research/biomarkers Year: 2009 Tiotropium bromide reduces PMN chemotaxis induced by alveolar macrophages of COPD patients Source: Annual Congress 2008 - Pathogenesis and treatment of asthma and COPD Year: 2008 Suppressive effects of formoterol and salmeterol on eotaxin-1 in bronchial epithelial cells Source: Annual Congress 2008 - Novel therapeutic approaches and immunological mechanisms in airway cell pathobiology Year: 2008 HDAC2-independent anti-inflammatory effects of budesonide in human lung fibroblasts Source: Annual Congress 2011 - Recent developments in COPD Year: 2011 Glucocorticoid sensitivity of LPS stimulated COPD alveolar macrophages Source: Annual Congress 2009 - COPD: basic science and clinical studies Year: 2009 Effect of inhaled budesonide on BAL inflammatory cells and MMP-12 expression in COPD Source: Eur Respir J 2007; 30: Suppl. 51, 611s Year: 2007 Synergistic anti-inflammatory effects of salmeterol and fluticasone on the release of IL-8 and MCP-1 by human bronchial epithelial cells Source: Eur Respir J 2003; 22: Suppl. 45, 39s Year: 2003 Resveratrol impairs the release of steroid-resistant cytokines from bacterial endotoxin-exposed alveolar macrophages (AM) in COPD Source: Annual Congress 2011 - Experimental modulation of airway inflammation Year: 2011 Cigarette smoke-induced IL-8 production by human monocyte-derived macrophages: synergistic inhibition by fluticasone and salmeterol Source: Eur Respir J 2005; 26: Suppl. 49, 14s Year: 2005 Phenotype polarization of alveolar macrophages in COPD patients Source: Annual Congress 2010 - Macrophages: cell biology and disease-specific characteristics Year: 2010 Effect of nintedanib on the release of angiogenic/angiostatic cytokines by alveolar macrophages (AMs) in interstitial lung diseases (ILD) Source: International Congress 2015 – IPF: from bench to bedside Year: 2015 Fluticasone increases in vitro efferocytosis by human alveolar macrophages Source: Annual Congress 2010 - Asthma: clinical aspects and treatment Year: 2010 The inhibitory effect of formoterol and salmeterol on the IP-10 (CXCL10) in bronchial epithelial cells Source: Annual Congress 2009 - Models of chronic airways disease and therapy Year: 2009 Azithromycin increases phagocytosis of apoptotic bronchial epithelial cells by alveolar macrophages Source: Eur Respir J 2006; 28: 486-495 Year: 2006 Effects of formoterol and salmeterol on the production of Th1- and Th2-related chemokines by monocytes and bronchial epithelial cells Source: Eur Respir J 2008; 31: 1313-1321 Year: 2008 Allergen-induced airway decorin production is inhibited by budesonide and formoterol in a mouse model of asthma Source: Eur Respir J 2004; 24: Suppl. 48, 690s Year: 2004 Differences in efficacy between formoterol and salmeterol in relaxation of the mouse trachea are accentuated by inflammatory cytokines Source: Eur Respir J 2005; 26: Suppl. 49, 370s Year: 2005 The effect of in vitro culture methods on corticosteroid sensitivity in COPD alveolar macrophages Source: Annual Congress 2013 –COPD: experimental biology Year: 2013 Possible anti-inflammatory effect of salmeterol against interleukin-8 and neutrophil activation in asthma in vivo Source: Eur Respir J 2003; 21: 994-999 Year: 2003 Effects of formoterol and salmeterol on cytokine release from monocyte-derived macrophages Source: Eur Respir J 2010; 36: 178-186 Year: 2010